Cheryl Gurine Pfeifer

Title: Cheryl Gurine Pfeifer: Innovator in Antibody Research

Introduction

Cheryl Gurine Pfeifer is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of antibody research, particularly in the development of antibodies targeting L-type voltage-gated calcium channels. With a total of 2 patents, her work has implications for cancer treatment and immune response modification.

Latest Patents

Cheryl's latest patents include innovative methods and compositions related to antibodies that specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage-gated calcium channels. These antibodies and their antigen-binding fragments are designed for administration to subjects in need, aiming to modify immune responses, particularly in the context of cancer treatment.

Career Highlights

Cheryl is affiliated with the University of British Columbia, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in therapeutic settings, showcasing her dedication to advancing medical science.

Collaborations

Cheryl has collaborated with notable colleagues, including Wilfred A Jefferies and Kyung Bok Choi. These partnerships have enriched her research endeavors and contributed to the advancement of knowledge in her field.

Conclusion

Cheryl Gurine Pfeifer stands out as an influential inventor in the realm of antibody research. Her innovative patents and collaborations reflect her commitment to improving cancer treatment and understanding immune responses.